Literature DB >> 15060713

The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice.

M D Laurenti1, A Orn, I L Sinhorini, C E P Corbett.   

Abstract

Complement-depleted and -non-depleted BALB/c mice were inoculated with Leishmania (Leishmania) amazonensis promastigotes into the hind footpad to study the role of the complement system in cutaneous leishmaniasis. Total serum complement activity was measured by hemolytic assay and C3 fragment deposit at the inoculation site was determined by direct immunofluorescence in the early period of infection, i.e., at 3, 24, 48 h and 7 days post-infection. The inflammatory reaction and the parasite burden were evaluated in the skin lesion at 7 and 30 days post-infection. Total serum complement activity decreased in the early phase of infection, from 3 to 24 h, in non-depleted mice compared to non-infected and non-depleted mice. C3 fragment deposit at the site of parasite inoculation was present throughout the period of infection in non-depleted mice. In contrast, no C3 fragment deposit was observed at the inoculation site in complement-depleted mice. Complement-depleted mice showed a significant decrease in the inflammatory response and a significant increase in the number of parasites (70.0 +/- 5.3 vs 5.3 +/- 1.5) at 7 days of infection (P<0.05). A higher number of parasites were also present at 30 days of infection at the inoculation site of complement-depleted mice (78.5 +/- 24.9 vs 6.3 +/- 5.7). These experiments indicate that complement has an important role at the beginning of experimental cutaneous leishmaniasis caused by L. (L.) amazonensis by controlling the number of parasites in the lesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060713     DOI: 10.1590/s0100-879x2004000300021

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

1.  The hamster (Mesocricetus auratus) as an experimental model of toxocariasis: histopathological, immunohistochemical, and immunoelectron microscopic findings.

Authors:  Ana Maria Gonçalves da Silva; Pedro Paulo Chieffi; Wellington Luiz Ferreira da Silva; Edite Hatsumi Yamashiro Kanashiro; Guita Rubinsky-Elefant; Edécio Cunha-Neto; Eliane Conti Mairena; Thales De Brito
Journal:  Parasitol Res       Date:  2014-12-19       Impact factor: 2.289

2.  Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of BALB/c Mice Caused by Leishmania major.

Authors:  Seyedeh Noushin Zahedi; Seyed Hossein Hejazi; Maryam Boshtam; Farahnaz Amini; Hossein Fazeli; Mahdieh Sarmadi; Mahsa Rahimi; Hossein Khanahmad
Journal:  Acta Parasitol       Date:  2020-07-16       Impact factor: 1.440

Review 3.  Innate immunity against Leishmania infections.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Microbiol       Date:  2015-08-11       Impact factor: 3.715

Review 4.  Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.

Authors:  Áurea Gabriel; Ana Valério-Bolas; Joana Palma-Marques; Patrícia Mourata-Gonçalves; Pedro Ruas; Tatiana Dias-Guerreiro; Gabriela Santos-Gomes
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

Review 5.  The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-Leishmania amazonensis Interactions Lead to a Progressive Chronic Disease.

Authors:  Matheus B Carneiro; Nathan C Peters
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.